The WACC of Natraj Proteins Ltd (530119.BO) is 14.3%.
Range | Selected | |
Cost of equity | 16.70% - 22.80% | 19.75% |
Tax rate | 18.50% - 28.70% | 23.60% |
Cost of debt | 6.50% - 26.90% | 16.70% |
WACC | 8.4% - 20.1% | 14.3% |
Category | Low | High |
Long-term bond rate | 6.9% | 7.4% |
Equity market risk premium | 8.3% | 9.3% |
Adjusted beta | 1.18 | 1.61 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 16.70% | 22.80% |
Tax rate | 18.50% | 28.70% |
Debt/Equity ratio | 2.71 | 2.71 |
Cost of debt | 6.50% | 26.90% |
After-tax WACC | 8.4% | 20.1% |
Selected WACC | 14.3% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 530119.BO:
cost_of_equity (19.75%) = risk_free_rate (7.15%) + equity_risk_premium (8.80%) * adjusted_beta (1.18) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.